# SARS-CoV-2 vaccines induce a diverse spike-specific CD4+ T cell receptor repertoire in people living with HIV with low CD4 nadirs

**Authors:** Alicia Mercado, Joel Sop, Steven Amanat, Li Zhang, Natasha M. Chida, Christie R. Basseth, Kelly A. Gebo, Annukka A. R. Antar, Kellie N. Smith, Zhen Zeng, Joel N. Blankson

PMC · DOI: 10.3389/fimmu.2025.1663819 · 2025-10-13

## TL;DR

People with HIV and low CD4 counts can develop strong and diverse T cell responses to SARS-CoV-2 vaccines, with minimal influence from prior exposure to common cold coronaviruses.

## Contribution

Demonstrates robust and diverse SARS-CoV-2-specific CD4+ T cell responses in HIV-positive individuals with low CD4 nadirs following vaccination.

## Key findings

- Individuals with low CD4 counts showed strong T cell responses to SARS-CoV-2 spike protein.
- Cross-reactive TCRs from common cold coronaviruses made up less than 10% of SARS-CoV-2-specific T cells.
- SARS-CoV-2 T cell receptor diversity in HIV-positive individuals was comparable to that of healthy donors.

## Abstract

People living with HIV with low CD4 T cell nadirs on antiretroviral therapy have suboptimal responses to immunization. We analyzed the SARS-CoV-2 spike-specific CD4+ T cell repertoire in individuals with CD4 nadirs of less than 100 cells/ul who received a primary SARS-CoV-2 mRNA vaccine series as well as the bivalent ancestral/BA.5 spike mRNA vaccine. We tested the hypothesis that antigenic imprinting would result in the preferential expansion of pre-existing cross-reactive T cells that were primed against the 4 common cold coronaviruses. We found that these individuals made robust effector and memory T cell responses to the SARS-CoV-2 spike protein that exceeded the responses to spike proteins from the common cold coronaviruses. Furthermore, in 4 individuals, the number of SARS-CoV-2 specific TCRs far exceeded the number of common cold coronavirus-specific T cell receptors. TCRs that were cross-reactive for common cold coronaviruses and SARS-CoV-2 comprised less than 10% of the total detected SARS-CoV-2 specific T cells. The diversity of the SARS-CoV-2 spike-specific repertoire in 6 study participants was comparable to that of the repertoire in vaccinated HIV healthy donors. Our data suggests people living with HIV with low CD4 nadirs can have significant functional immune reconstitution with little evidence of antigenic imprinting due to pre-existing T cell responses to common cold coronaviruses.

## Linked entities

- **Proteins:** CD4 (CD4 molecule)
- **Diseases:** SARS-CoV-2 (MONDO:0100096)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, S (surface glycoprotein) [NCBI Gene 43740568] {aka spike glycoprotein}
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12554773/full.md

---
Source: https://tomesphere.com/paper/PMC12554773